Skip to main content
OGN
NYSE Life Sciences

Organon's Tofidence Biosimilar Gains FDA Approval for Expanded Use in Cancer and COVID-19

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$13.38
Mkt Cap
$3.519B
52W Low
$5.69
52W High
$13.48
52W Position info
135% above low
Off High info
at 52W high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

OGN has more than doubled off its 52-week low of $5.69 on light trading volume (0.2× avg).

Summary

Organon received FDA approval to expand the use of its biosimilar drug, Tofidence, for severe cytokine release syndrome in cancer patients and for COVID-19 patients requiring breathing support. This regulatory win broadens the market for Tofidence, which is a biosimilar to Roche's Actemra. However, the company is currently under a definitive merger agreement to be acquired by Sun Pharmaceutical for $14.00 per share, which limits the immediate upside impact of this positive news on Organon's stock price.

At the time of this announcement, OGN was trading at $13.38 on NYSE in the Life Sciences sector, with a market capitalization of approximately $3.5B. The 52-week trading range was $5.69 to $13.48. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

OGN - Latest Insights

OGN
Oct 30, 2026, 8:03 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $13.83
Real-time Price: $13.89 info
Change: +$0.0593 (+0.43%) info
Market Cap: $3.635B info
OGN
Oct 21, 2026, 6:32 AM EDT
Source: Businessworld
Importance Score:
7
Price at Filing: $13.74
Real-time Price: $13.89 info
Change: +$0.1496 (+1%) info
Market Cap: $3.635B info
OGN
Oct 16, 2026, 7:30 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $13.77
Real-time Price: $13.89 info
Change: +$0.1204 (+0.87%) info
Market Cap: $3.635B info
OGN
Jul 31, 2026, 8:06 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $13.53
Real-time Price: $13.89 info
Change: +$0.3596 (+3%) info
Market Cap: $3.635B info
OGN
Jul 24, 2026, 1:42 AM EDT
Source: Moneycontrol
Importance Score:
8
Price at Filing: $13.56
Real-time Price: $13.89 info
Change: +$0.3296 (+2%) info
Market Cap: $3.635B info